{"id":"NCT00121667","sponsor":"AstraZeneca","briefTitle":"Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone","officialTitle":"\"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial to Evaluate the Efficacy and Safety of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone\"","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08","primaryCompletion":"2006-10","completion":"2010-02","firstPosted":"2005-07-21","resultsPosted":"2011-04-08","lastUpdate":"2015-04-29"},"enrollment":1462,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Saxagliptin + Metformin","otherNames":["BMS-477118"]},{"type":"DRUG","name":"Saxagliptin + Metformin","otherNames":["BMS-477118"]},{"type":"DRUG","name":"Saxagliptin + Metformin","otherNames":["BMS-477118"]},{"type":"DRUG","name":"Placebo + Metformin","otherNames":[]},{"type":"DRUG","name":"Pioglitazone","otherNames":[]}],"arms":[{"label":"Saxagliptin + Metformin (A)","type":"EXPERIMENTAL"},{"label":"Saxagliptin + Metformin (B)","type":"EXPERIMENTAL"},{"label":"Saxagliptin + Metformin (C)","type":"EXPERIMENTAL"},{"label":"Placebo+ Metformin (D)","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone","primaryOutcome":{"measure":"Baseline and Change From Baseline in Hemoglobin A1c (A1C) at Week 24","timeFrame":"Baseline, Week 24","effectByArm":[{"arm":"Saxagliptin 2.5 mg + Metformin","deltaMin":8.08,"sd":0.07},{"arm":"Saxagliptin 5 mg + Metformin","deltaMin":8.07,"sd":0.06},{"arm":"Saxagliptin 10 mg + Metformin","deltaMin":7.98,"sd":0.08},{"arm":"Placebo+ Metformin","deltaMin":8.06,"sd":0.07}],"pValues":[{"comp":"OG000 vs OG003","p":"<.0001"},{"comp":"OG001 vs OG003","p":"<.0001"},{"comp":"OG002 vs OG003","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":152,"countries":["United States","Argentina","Australia","Brazil","Canada","Chile","Mexico","Puerto Rico","Taiwan"]},"refs":{"pmids":["19478198","31364269","27402391","27033025","23802840","23795975","21680990"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":179},"commonTop":["INFLUENZA","NASOPHARYNGITIS","HEADACHE","DIARRHOEA","UPPER RESPIRATORY TRACT INFECTION"]}}